Solventum

SOLV · NYSE · USD

$87.85+0.09%+$0.08

Close · October 2, 2026

At a glance

Revenue growth
+0.86%
2025 vs 2024
Net income growth
+224.84%
2025 vs 2024
Net margin
18.7%
2024: 5.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Total revenue2,2092,0061,9982,0962,161
Cost of revenue923911971961986
Gross profit1,2861,0951,0271,1351,175
Selling, general and administrative927827759780772
Research and development178189175183189
Operating income18179.093.0172214
EBIT17278.01091,603206
EBITDA3052132261,724328
Interest expense64.062.051.089.0103
Pre-tax income10816.058.01,514103
Income tax15.03.0-5.024813.0
Net income92.013.063.01,26690.0
Net income to common shareholders92.013.063.01,26690.0
Basic EPS0.530.070.367.260.52
Diluted EPS0.530.070.367.220.51
Average shares (basic)173174174174174
Average shares (diluted)173176176175175